Nurx’ $52 Million Fundraising


Fenwick & West represented Nurx in the transaction.

Nurx Inc. is a health tech company providing convenient and affordable care for sensitive health needs.

The Series C round was led by Kleiner Perkins Digital Growth Fund and Union Square Ventures with participation from Reproductive Health Investors Alliance, Dreamers VC, Lowercase Capital and Y Combinator, as well as Triple Point Capital for equity and debt.

Nurx will use the funds to introduce more services for sensitive health needs, as well as grow its patient community to reach more people who face systemic barriers to healthcare. The company will also focus on expanding its medical provider team and investing in its telemedicine platform to continue improving and streamlining the patient experience.

Fenwick represented Nurx with a team led by corporate partners Michael Esquivel (Picture) and Faisal Rashid and associates Will Black, Elliot Ginsburg and Harrison Dilday.

Involved fees earner: Will Black – Fenwick & West LLP; R. Harrison Dilday – Fenwick & West LLP; Michael Esquivel – Fenwick & West LLP; Elliot Ginsburg – Fenwick & West LLP; Faisal Rashid – Fenwick & West LLP;

Law Firms: Fenwick & West LLP;

Clients: Nurx Inc.;

Author: Ambrogio Visconti